Stock News

Contrarian Capital Management – L.L.C. Insider in Vanguard Natural Resources, Inc. (VNRR), Obtained 84,932 Shares; Parallax Volatility Advisers LP Has Decreased Regeneron Pharmaceuticals (REGN) Stake By $637,875

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Logo

Parallax Volatility Advisers Lp decreased Regeneron Pharmaceuticals (REGN) stake by 34.02% reported in 2017Q4 SEC filing. Parallax Volatility Advisers Lp sold 1,701 shares as Regeneron Pharmaceuticals (REGN)’s stock declined 13.59%. The Parallax Volatility Advisers Lp holds 3,299 shares with $1.24 million value, down from 5,000 last quarter. Regeneron Pharmaceuticals now has $32.51B valuation. The stock increased 0.42% or $1.25 during the last trading session, reaching $301.7. About 349,217 shares traded. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has declined 14.19% since May 16, 2017 and is downtrending. It has underperformed by 25.74% the S&P500.

More notable recent Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) news were published by: Seekingalpha.com which released: “Regeneron: Initiating At These Levels” on May 10, 2018, also Seekingalpha.com with their article: “Why Regeneron Has 30 Percent Upside” published on May 07, 2018, Streetinsider.com published: “Sanofi (SNY) & Regeneron (REGN) Report Dupixent (dupilumab) Showed Positive Phase 3 Results in Adolescents …” on May 16, 2018. More interesting news about Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) were released by: Benzinga.com and their article: “Regeneron Pharmaceuticals: Sequencing Its Way to +30% Upside” published on May 03, 2018 as well as Nasdaq.com‘s news article titled: “Why The Trade Desk, Noodles & Co., and Regeneron Pharmaceuticals Jumped Today” with publication date: May 11, 2018.

Analysts await Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to report earnings on August, 2. They expect $4.39 EPS, up 13.14% or $0.51 from last year’s $3.88 per share. REGN’s profit will be $473.05M for 17.18 P/E if the $4.39 EPS becomes a reality. After $3.98 actual EPS reported by Regeneron Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 10.30% EPS growth.

Among 33 analysts covering Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), 11 have Buy rating, 1 Sell and 21 Hold. Therefore 33% are positive. Regeneron Pharmaceuticals Inc. had 126 analyst reports since July 28, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Monday, August 14 by J.P. Morgan. The rating was maintained by Morgan Stanley with “Equal-Weight” on Friday, February 9. Robert W. Baird upgraded Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Friday, November 3 to “Neutral” rating. Argus Research maintained Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Thursday, August 6 with “Buy” rating. The stock has “Buy” rating by BTIG Research on Friday, June 30. The stock of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has “Sell” rating given on Monday, January 25 by Chardan Capital Markets. The stock of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has “Neutral” rating given on Wednesday, January 24 by JP Morgan. The stock of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) earned “Neutral” rating by TH Capital on Monday, August 10. Canaccord Genuity upgraded the stock to “Buy” rating in Friday, May 5 report. Northland Capital initiated Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) rating on Wednesday, July 22. Northland Capital has “Market Perform” rating and $560 target.

Investors sentiment is 1.17 in 2017 Q4. Its the same as in 2017Q3. It is without change, as 62 investors sold REGN shares while 161 reduced holdings. only 71 funds opened positions while 191 raised stakes. 69.17 million shares or 6.15% less from 73.70 million shares in 2017Q3 were reported. Ontario – Canada-based Cibc World Markets Inc has invested 0% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Cibc World Mkts owns 27,180 shares. Andra Ap accumulated 5,400 shares or 0.05% of the stock. Stonebridge Capital Mngmt Inc reported 1,728 shares or 0.23% of all its holdings. Highlander Mngmt Ltd Co, a New Jersey-based fund reported 50 shares. Campbell Co Adviser Limited, a Maryland-based fund reported 1,135 shares. Pictet Asset Mgmt Ltd owns 0.39% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for 402,518 shares. Sg Americas Secs reported 0.04% stake. Northwestern Mutual Wealth Mngmt owns 0% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for 1,791 shares. The New York-based Millennium Management Limited Liability Co has invested 0.25% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Norinchukin State Bank The reported 6,160 shares or 0.04% of all its holdings. Moors And Cabot has invested 0.03% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Eaton Vance Mngmt has 63,602 shares. New York State Common Retirement Fund stated it has 226,909 shares or 0.1% of all its holdings. Captrust Fin Advsrs has invested 0% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN).

Parallax Volatility Advisers Lp increased Waste Mgmt Inc Del (NYSE:WM) stake by 9,326 shares to 9,343 valued at $806,000 in 2017Q4. It also upped Herbalife Ltd (Call) (NYSE:HLF) stake by 220,000 shares and now owns 263,000 shares. Newell Brands Inc (Call) (NYSE:NWL) was raised too.

Since February 9, 2018, it had 0 buys, and 4 selling transactions for $7.43 million activity. $680,000 worth of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) was sold by GOLDSTEIN JOSEPH L. SING GEORGE L also sold $5.72M worth of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Wednesday, May 9.

Vanguard Natural Resources, Inc., an independent gas and oil company, focuses on the acquisition, production, and development of oil and natural gas properties. The company has market cap of $130.85 million. The Company’s assets consist primarily of producing and non-producing oil and natural gas reserves located in the Green River Basin in Wyoming; the Permian Basin in West Texas and New Mexico; the Gulf Coast Basin in Texas, Louisiana, Mississippi, and Alabama; the Anadarko Basin in Oklahoma and North Texas; the Piceance Basin in Colorado; the Big Horn Basin in Wyoming and Montana; the Arkoma Basin in Arkansas and Oklahoma; the Williston Basin in North Dakota and Montana; the Wind River Basin in Wyoming; and the Powder River Basin in Wyoming. It currently has negative earnings.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *